EZH2 and breast cancer: Studies have demonstrated that EZH2 is significantly up-regulated in various malignancies, including esophageal cancer, breast cancer, gastric cancer, anaplastic thyroid cancer, nasopharyngeal cancer, and endometrial cancer [10,14,15,16].